QR kód

Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Difloxacin (A-56619) and A-56620, two novel fluoroquinolones, were tested in comparison with ciprofloxacin, cefoxitin, and combined clindamycin and gentamicin in the treatment of experimentally induced intraabdominal abscess associated with Bacteroides fragilis. Difloxacin was found to be as effecti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Thadepalli, H, Gollapudi, S V, Chuah, S K
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 1986
Témata:
On-line přístup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176483/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3539011/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.4.574
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!